Case StudiesMeeting Randomization and Supply Challenges in an Innovative Dermatology Study
Orion Utilizes Metrics to Refine Clinical Development Processes
INC Research Leads the Way for Risk-Based Monitoring Using Medidata Targeted SDV Solution
SGS Life Science Services Uses Medidata CTMS™ to Cut Site Payment Process Times by Over 60 Percent
Medidata and InterMune Work Together to Integrate Clinical and Safety Databases
Nordic Bioscience Targets 20% SDV with Risk-Based Monitoring to
Streamline Clinical Trial Execution
Randomization Solution Speeds Oncology Study through Integrated
Platform and Rapid CRO Training
Abbott: Transforming Clinical Business with an Enterprise Approach to EDC
Lowering Clinical Trial Costs with a Trial Planning and Budgeting Application
Solving the Compliance Challenge for Investigator Clinical Research Payments
Meeting the Challenges of a Multinational Late Phase Study
Mastering Mid-Study Changes: ICON Clinical Research Draws on Medidata Rave
for Smooth Data Migrations
Industry Analyst ReportsHealth Industry Insights (IDC): Vendor Assessment: 2012 Top 10 Life Science Software Vendors
Health Industry Insights (IDC): Vendor Assessment: 2011 Top 10 Life Science Software Vendors
Health Industry Insights (IDC): Medidata Brings Intelligent Design to Clinical Trials
PodcastsSynergism principal Kelly Willenberg and Medidata vice president of data operations Lori Shields discuss and debate the key issues that divide sites and sponsors, and the new methods and technology that can offer near-term and lasting solutions in a Bio-IT World podcast.
Global Biopharm Solutions president Steven Jacobs and Medidata director of Balance Solutions Ehsan Ramezani discuss the changes taking place in the clinical trial randomization and supply management arena, as well as the available solutions that appear to address the ongoing challenges in a Bio-IT World podcast.
CEO & president of the Halloran Consulting Group Laurie Halloran and Medidata senior product director Steve Young discuss how clinical business analytics can help sponsors effectively mine the unprecedented amounts of data now available to clinical operations departments to make more informed decisions in a Bio-IT World podcast.
Senior research fellow at the Tufts Center for the Study of Drug Development Ken Getz and Medidata vice president of data operations Lori Shields discuss how increasing trial complexity affects trial success, how to anticipate and manage trial hurdles and how to motivate trial progress through metrics in a Bio-IT World podcast.
Medidata vice president of strategic regulatory initiatives Patricia Beers Block and senior product director Steve Young address questions on how today’s challenging environment is prompting study teams to explore the use of risk-based approaches to monitoring that do not compromise data quality. They discuss how limited resources can be directed more effectively to where they’re most needed and to the most critical review activities in a Bio-IT World podcast.
Medidata vice president of quality assurance Fran Nolan and BLCMD Associates president Dr. Barton Cobert address drug safety regulation challenges that the biopharmaceutical industry is facing in clinical trials and the emerging new technologies that can help researchers address them in a Bio-IT World podcast.
Medidata vice president of alliances Anne Zielinski and Monitor For Hire president Scott Freedman discuss how technology is altering the landscape for clinical monitors and impacting the success of clinical studies in a Bio-IT World podcast.
Medidata president Glen de Vries and SAS global director of health and life sciences market segments Jason Burke discuss the current state of health business innovation, particularly around providing solutions for clinical trials and drug development in a Bio-IT World podcast.
Senior research fellow at the Tufts Center for the Study of Drug Development Ken Getz and Medidata general manager of trial planning solutions Ed Seguine address the cause, not symptoms, of rising clinical trial delays and costs in a Bio-IT World podcast.
Medidata and other industry thought leaders share the steps to shaping success in adaptive clinical trials in a Future Pharmaceuticals podcast.
Listen | Read
White PapersAdopting Site Quality Management to Optimize Risk-Based Monitoring
In today’s pressure-packed environment, the quest for improved data quality at a lower cost is of paramount importance to all clinical organizations. A risk-based model for monitoring has become a growing and crucial component in this search. This white paper will break down the issues related to the implementation and tracking of a risk-based monitoring program.
Medidata Balance: Innovation in Randomization and Trial Supply Management
Methods for randomization and managing trial supplies have long been known as lengthy and costly processes to set up and manage. However, the introduction of Medidata Balance™ to the life science industry has introduced a new paradigm for randomization and trial supply management (RTSM), offering a wide array of features that shorten deployment time, maximize site effectiveness and offer exceptional ease of use for the whole research team. This white paper provides an in-depth look at how Balance can help sponsors enhance their clinical trials, achiever greater return on investment and reduce risk.
Medidata's Approach to Today's Drug Development Dilemmas
Today's competitive biopharmaceutical environment demands a comprehensive integration of technologies that support the clinical development process. But companies are faced with many challenges and limitations imposed by commonly used clinical research point solution technologies. This white paper outlines how Medidata Solution’s approach is unifying clinical development and clinical trial execution through technology that addresses clinical research needs from trial concept to conclusion.
Using Technology to Deliver Complex Oncology Trials
Accelerating the outputs of clinical research, identifying sub-optimal treatments quickly and refocusing efforts on treatments that look more likely to succeed are pressing goals of oncology R&D organizations. This white paper explores how advanced technology available today offers the efficiency, speed and data visibility to help yield these results for research organizations.
Cloud Computing—Driving Security, Performance and Quality
This Medidata white paper explores how cloud computing drives specific regulatory and IT-security considerations in our industry that need to be correctly addressed, but also gives software providers such as Medidata the opportunity to offer customers products and services of a much higher quality and integrity than previously available to the industry.
Transforming Randomization and Trial Supply Management
A Medidata white paper presenting Medidata Balance and comparing its use and operation with other randomization and trial supply management (RTSM) methods.
Best Practice Clinical Trial Pricing Using Benchmark Data
A Medidata white paper examining the results of a survey and three case studies to provide insights on lowering the costs of clinical trials while still paying accurately.
Racial Disparities Among Clinical Research Investigators
A report by the American Journal of Therapeutics detailing the underrepresentation of minority patients in clinical trials.
The eClinical Equation Part 1—Electronic Data Capture
An IBM white paper offers strategic insight on the EDC market and describes why after extensive investigations and analysis, IBM and Bayer unanimously agreed on the selection of Medidata Rave for Bayer's new EDC system.